Precigen Inc. (PGEN) Misses Q2 EPS by 13c, Misses on Revenue

Precigen Inc. (NASDAQ: PGEN) reported Q2 EPS of ($0.23), $0.13 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $717 thousand versus the consensus estimate of $1.28 million.

For earnings history and earnings-related data on Precigen Inc. (PGEN) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
• Indaptus Therapeutics (INDP) files for 59M share offering by selling stockholders